HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pham Ngoc Khoi Selected Research

RON protein

1/2020Lysophosphatidic Acid Upregulates Recepteur D'origine Nantais Expression and Cell Invasion via Egr-1, AP-1, and NF-κB Signaling in Bladder Carcinoma Cells.
4/2015Chrysin inhibits cell invasion by inhibition of Recepteur d'origine Nantais via suppressing early growth response-1 and NF-κB transcription factor activities in gastric cancer cells.
3/2013EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells.
2/2011MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pham Ngoc Khoi Research Topics

Disease

10Neoplasms (Cancer)
05/2022 - 03/2012
10Stomach Neoplasms (Stomach Cancer)
05/2022 - 02/2011
8Neoplasm Metastasis (Metastasis)
05/2022 - 09/2013
2Inflammation (Inflammations)
12/2015 - 03/2012
1Carcinoma (Carcinomatosis)
01/2020
1Carcinogenesis
03/2013

Drug/Important Bio-Agent (IBA)

5Transcription Factor AP-1 (Transcription Factor AP 1)IBA
05/2022 - 02/2011
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2022 - 09/2013
4RON proteinIBA
01/2020 - 02/2011
4Urokinase Plasminogen Activator ReceptorsIBA
01/2017 - 02/2011
2PhytochemicalsIBA
05/2022 - 04/2015
2AlkaloidsIBA
05/2022 - 01/2015
2p38 Mitogen-Activated Protein KinasesIBA
05/2022 - 01/2015
2Interleukin-8 (Interleukin 8)IBA
01/2016 - 12/2013
2CarcinogensIBA
12/2015 - 01/2015
2CadmiumIBA
12/2015 - 10/2014
2chrysinIBA
04/2015 - 01/2015
2Small Interfering RNA (siRNA)IBA
01/2015 - 03/2013
1sulforaphaneIBA
05/2022
1NicotineFDA Link
05/2022
1lysophosphatidic acidIBA
01/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2020
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2017
1Dinoprostone (PGE2)FDA Link
01/2017
1Carbon MonoxideIBA
01/2016
1Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
01/2016
1InterleukinsIBA
01/2016
1tricarbonyldichlororuthenium (II) dimerIBA
01/2016
1AntioxidantsIBA
01/2016
1Environmental Pollutants (Pollutants, Environmental)IBA
12/2015
1Transcription Factors (Transcription Factor)IBA
04/2015
1FlavonoidsIBA
04/2015
1CytokinesIBA
01/2015
1Peptide Hydrolases (Proteases)FDA Link
01/2015
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2015
1piperineIBA
01/2015
1Interleukin-6 (Interleukin 6)IBA
01/2015
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
03/2013
1Catechin (Z 7300)IBA
03/2013
1TeaIBA
03/2013
1ElementsIBA
03/2013
1LigandsIBA
02/2011
1macrophage stimulating proteinIBA
02/2011

Therapy/Procedure

2Therapeutics
05/2022 - 12/2013